Fachrepositorium Lebenswissenschaften

16 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition

2022 . Phetphoung, Thareeya | Malla, Ashwini | Rattanapisit, Kaewta | Pisuttinusart, Nuttapat | Damrongyot, Naruechai | Joyjamras, Keerati | Chanvorachote, Pithi | Phakham, Tanapati | Wongtangprasert, Tossapon | Strasser, Richard | Chaotham, Chatchai | Phoolcharoen, Waranyoo

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

2021 . Taugner, Julian | Käsmann, Lukas | Karin, Monika | Eze, Chukwuka | Flörsch, Benedikt | Guggenberger, Julian | Li, Minglun | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial

2021 . Christopoulos, Petros | Bozorgmehr, Farastuk | Brückner, Lena | Chung, Inn | Krisam, Johannes | Schneider, Marc A. | Stenzinger, Albrecht | Eickhoff, Regina | Mueller, Daniel W. | Thomas, Michael

A Modified Calculation Improves the Accuracy of Predicted Postoperative Lung Function Values in Lung Cancer Patients

2021 . Schlachtenberger, Georg | Doerr, F. | Menghesha, H. | Hagmeyer, L. | Leschczyk, T. | Gaisendrees, C. | Michel, M. | Wahlers, T. | Hekmat, K. | Heldwein, M. B.

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing

Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report

2021 . Blasi, Miriam | Kazdal, Daniel | Thomas, Michael | Christopoulos, Petros | Kriegsmann, Mark | Brandt, Regine | Volckmar, Anna-Lena | Kirchner, Martina | Heußel, Claus Peter | Stenzinger, Albrecht | Kuon, Jonas

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients

2021 . Taugner, Julian | Käsmann, Lukas | Eze, Chukwuka | Rühle, Alexander | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics

2021 . Neumann, Judith Martha | Freitag, Hinrich | Hartmann, Jasmin Saskia | Niehaus, Karsten | Galanis, Michail | Griesshammer, Martin | Kellner, Udo | Bednarz, Hanna

Seiten